$BEAM was mentioned 30 times across 12 months by 6 distinct FinTwit voices, with the first mention on September 3, 2025. The most-active voice discussing $BEAM was @vulturetrades with 12 mentions, followed by @cobraalerts with 7 mentions and @investmentguru_ with 6 mentions. The dominant discussion category was long research. Recent commentary from July 2026 included @adamfeuerstein sharing critical remarks about $BEAM's progress in sickle cell gene therapy, while @investmentguru_ positioned $BEAM among 15 biotechnology stocks to watch, describing it as specializing in base-editing gene technology for DNA correction.